Fetal survival in abdominal pregnancy: A review of 11 cases
β Scribed by Dubinsky, Theodore J.; Guerra, Francisco; Gormaz, Gustavo; Maklad, Nabil
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 534 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0091-2751
No coin nor oath required. For personal study only.
β¦ Synopsis
Purpose: Little has been written regarding the ultrasound imaging features that might allow prediction of fetal viability in abdominal pregnancies. Toward this goal, we present our experience with a series of 11 abdominal pregnancies.
Materials and Methods: From 1981 to 1993, 11 patients presented to Universidad Catolica, Santiago, and Universidad de Austral, Valdivia, Chile, with third trimester abdominal pregnancies. Five had complete ultrasound examinations, and these five patients were managed expectantly. The other six women presented as acute abdominal emergencies and underwent emergent surgery.
Results: Four of five fetuses that survived had a complete placental attachment to the uterus, and one surviving neonate had a partial attachment of the placenta to the uterus. Three fetuses died prior to delivery, and all three had a complete mesenteric placental attachment. Two died in the early neonatal period. One had a complete uterine placental attachment, and the other had a partial attachment.
Conclusions: The survival rate of abdominal pregnancies may be better than is generally believed. Placental attachment to the uterus appears t o be a factor related to fetal survival and maternal morbidity. More cases are necessary to determine the feasibility of managing women with abdominal pregnancies expectantly.
π SIMILAR VOLUMES
Pregnancy is rare in Parkinson's disease (PD). In the literature on studies of antiparkinsonian drugs in animals during pregnancy, there are reports on malformations of the skeletal and circulatory system. However, the majority of studies in animals have not shown any teratogenicity. Amantadine has
A patient being treated for sickle cell disease with hydroxyurea (1 g/d) conceived, and drug treatment was discontinued at nine weeks gestational age. The pregnancy and delivery were complicated by vaso-oclusive crises. A healthy male infant was born at 39 weeks with no evidence of congenital malfor